|Bid||12.300 x 0|
|Ask||12.320 x 0|
|Day's Range||12.220 - 12.500|
|52 Week Range||6.930 - 12.720|
|PE Ratio (TTM)||34.95|
|Earnings Date||Aug 22, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||12.98|
HONG KONG, March 20, 2017 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (1093.HK) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company in China, is pleased to announce its annual results for the year ended 31 December 2016 (the "Year"). During the Year, the Group recorded sales of approximately HK$12,369 million, representing an increase of 8.6% (or increase of 15.3% on a constant currency basis) over the previous year.
CSPC Pharmaceutical (CHPTY) can be an exciting pick in the market as the firm saw robust EPS growth last year, and is looking great for this year too.
One company that might be well-positioned for future earnings growth is CSPC Pharmaceutical Group Limited (CHPTY)